Rayonier Advanced Materials Maps Risky Turnaround Path

Rayonier Advanced Materials ((RYAM)) has held its Q4 earnings call. Read on for the main highlights of the call.

Rayonier Advanced Materials’ latest earnings call struck a cautiously constructive tone as management laid out a detailed turnaround roadmap against a tough backdrop of negative free cash flow, high‑cost debt and structural oversupply. Executives emphasized pricing power and cost actions as early proof points, but acknowledged meaningful execution and refinancing risk that leaves investors weighing upside potential against near‑term uncertainty.

Pricing Reset in Cellulose Specialties

Rayonier Advanced Materials reported that roughly 85% of its cellulose specialties portfolio is now arranged at an average price increase of about 18% versus 2025 levels. Management signaled that the remaining 15%, still under negotiation, will likely need to clear at even higher prices to justify allocation or else be diverted into lower‑value markets.

Outsized Gains in Ether and Nitration Grades

Within specialties, pricing strength is most pronounced in ether‑grade and nitration‑grade cellulose, especially in Europe. The company said ether‑grade contracts are landing close to 20% higher, while nitration‑grade prices are rising more than 18% amid strong demand from propellant customers, underscoring selective pricing power despite global competition.

Laser Focus on 2026 Free Cash Flow Turnaround

After posting negative free cash flow of $88 million in 2025, management framed its number‑one priority as delivering positive free cash flow in 2026. Leaders stressed that every business unit is aligned to this mission, tying commercial, operational and capital allocation decisions to achieving a clear cash inflection next year.

EBITDA Recovery Across All Business Lines

Management expects EBITDA to improve in every segment in 2026 compared with 2025, despite guiding to roughly break‑even EBITDA in the first quarter. The company is counting on the new pricing structure, cost discipline and operational initiatives to drive a full‑year EBITDA result that is “substantially” higher than last year.

New Products to Support Margins and Growth

Rayonier Advanced Materials highlighted a growing innovation pipeline aimed at offsetting inflation and lifting margins, particularly in paperboard and pulp. Examples include oil and grease‑resistant board, a foldable freezer board offering and a higher‑value high‑yield pulp product now in customer testing, all intended to diversify earnings and de‑risk the portfolio.

Driving Tardis and BioNova for Biomaterials Growth

Operational issues at the Tardis site have constrained feedstock to the BioNova biomaterials joint venture, limiting ethanol and lignosulfonate output. To address this, the company has launched a crisis management team to run Tardis harder, with the goal of stabilizing production and enabling biomaterials to contribute more meaningfully to revenue growth.

Trade Remedies as a Potential Pricing Catalyst

Management pointed to pending trade cases as a potential tailwind for North American pricing, particularly against subsidized Brazilian imports. Preliminary countervailing duty decisions are expected in March, followed by antidumping determinations in May for Brazil and Norway, and any remedies could stack to support domestic price realization.

Paperboard Shows Sequential Volume and Price Gains

The paperboard segment posted sequential improvements in both volume and pricing in the fourth quarter, breaking from a difficult industry backdrop. Executives credited new product introductions such as freezer board, better mill productivity and quality, and a more favorable product mix that reduced culls and improved average realizations.

Cash Burn and High‑Cost Debt Remain Central Risks

Despite the strategy reset, the company’s capital structure remains a pressing concern as it exits 2025 with negative free cash flow and sizable high‑cost debt. Management labeled this situation unsustainable and is counting on operational execution and an eventual refinancing to cut interest expense and relieve pressure on fixed charges.

Pricing Comes with Planned Volume Declines

The step‑change in cellulose specialties pricing is expected to reduce demand materially, with volumes on the contracted book projected to fall around 20% versus 2025. This trade‑off should support margins but will create near‑term headwinds for revenue and plant utilization, adding another variable to the earnings recovery path.

Unplaced Specialties Expose Demand and Mix Uncertainty

Roughly 15% of the cellulose specialties portfolio remains unplaced, introducing uncertainty around final 2026 volumes and mix. Management said these tons will need materially higher prices than the 18% average to stay in specialties, otherwise they may be redirected into less profitable commodity applications.

Competitive and Import Pressures Shape Strategy

The company continues to face intense competition from low‑cost Chinese commodity producers in Europe and subsidized Brazilian imports in North America, which have weakened pricing and contributed to industry closures. This backdrop is reinforcing the shift toward higher‑value specialties and trade actions as key levers to defend domestic economics.

Oversupply Weighs on Paperboard and High‑Yield Pulp

Structural oversupply persists in paperboard and high‑yield pulp, suppressing pricing power and limiting volume recovery despite some green shoots. Rayonier Advanced Materials is testing a differentiated high‑yield pulp product that could help carve out more resilient demand, but acknowledged that a broader industry rebalance will be needed to fully restore margins.

Operational Strains and Project Discipline

Beyond Tardis, management flagged broader execution risk by noting its decision not to participate in a Georgia energy project, reflecting a more cautious stance on capital commitments. The combination of recent operational hiccups and select project pullbacks underscores the complexity of executing a turnaround while maintaining reliability and cost control.

Balance Sheet Constraints and Refinancing Imperative

The current capital structure is acting as a ceiling on performance, with high interest costs consuming cash that could otherwise support reinvestment. Management made clear that a refinancing is a strategic priority, as reducing interest and fixed charges is critical to making the operational and pricing gains visible at the bottom line.

Guidance Points to 2026 Cash Inflection and EBITDA Lift

Looking ahead, Rayonier Advanced Materials is guiding to “solid” positive free cash flow in 2026 and a substantial EBITDA improvement versus 2025, even as the first quarter hovers near break‑even. The outlook assumes successful execution on pricing, especially on the remaining 15% of specialties, incremental upside from trade remedies and a refinancing that lowers interest expense and builds momentum into 2027.

Rayonier Advanced Materials’ earnings call outlined a disciplined but challenging path from cash burn to cash generation, anchored by aggressive pricing, portfolio upgrades and tighter operations. Investors will be watching whether management can navigate volume losses, trade decisions and refinancing risk to convert today’s cautiously optimistic narrative into durable earnings and a stronger balance sheet.